These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19734408)

  • 1. Re: Myocardial infarction associated with Adderall XR and alcohol use in a young man.
    Pomeroy D
    J Am Board Fam Med; 2009; 22(5):590; author reply 590. PubMed ID: 19734408
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial infarction associated with adderall XR and alcohol use in a young man.
    Jiao X; Velez S; Ringstad J; Eyma V; Miller D; Bleiberg M
    J Am Board Fam Med; 2009; 22(2):197-201. PubMed ID: 19264944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
    Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
    J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: preliminary report.
    Matsumoto T; Kamijo A; Yamaguchi A; Iseki E; Hirayasu Y
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):102-5. PubMed ID: 15679548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I Have Never Used Methamphetamine, But My Urinalysis Says I Do.
    Sethi R; Din A; McAllister R; Lester A
    Prim Care Companion CNS Disord; 2018 Oct; 20(5):. PubMed ID: 30407755
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction in a teenager due to Adderall XR.
    Sylvester AL; Agarwala B
    Pediatr Cardiol; 2012 Jan; 33(1):155-7. PubMed ID: 21842255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
    Eggertson L
    CMAJ; 2005 Mar; 172(7):865. PubMed ID: 15758187
    [No Abstract]   [Full Text] [Related]  

  • 12. A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism.
    Woodard C; Groden J; Goodwin M; Bodfish J
    Autism; 2007 Jan; 11(1):29-41. PubMed ID: 17175572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder.
    Wilson HK; Cox DJ; Merkel RL; Moore M; Coghill D
    Arch Clin Neuropsychol; 2006 Dec; 21(8):797-807. PubMed ID: 17049803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 15. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not acute myocardial infarction in a teenager due to Adderall XR.
    Rosenthal E
    Pediatr Cardiol; 2012 Apr; 33(4):679. PubMed ID: 22354226
    [No Abstract]   [Full Text] [Related]  

  • 17. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
    Faraone SV; Wigal SB; Hodgkins P
    J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse.
    Salo R; Nordahl TE; Leamon MH; Natsuaki Y; Moore CD; Waters C; Carter CS
    Psychiatry Res; 2008 Jan; 157(1-3):273-7. PubMed ID: 17928066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.